United Health Products, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 17, 2021 at 02:36 am IST
Share
United Health Products, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 1.300 million compared to USD 647,876 a year ago. Net loss was USD 1.304 million compared to USD 693,052 a year ago. Basic loss per share from continuing operations was USD 0.01. For the half year, sales was USD 59 compared to USD 427 a year ago. Operating loss was USD 28.005 million compared to USD 1.271 million a year ago. Net loss was USD 28.351 million compared to USD 1.318 million a year ago. Basic loss per share from continuing operations was USD 0.13 compared to USD 0.01 a year ago.
United Health Products, Inc. develops, manufactures, and markets a hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. HemoStyp hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis. Its customer base includes hospitals, surgery centers, clinics and others.
UNITED HEALTH PRODUCTS, INC. 
